SCHEMBL7569199

SCHEMBL7569199

CC(OC1CCCCN1C(=O)O)c1ccc2ccccc2c1

nearest known ligand 0.44

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
SLC6A3 Q01959 5/20 0.44
SLC6A2 P23975 3/20 0.41
SLC6A4 P31645 3/20 0.41
KDM4E B2RXH2 1/20 0.40
ALDH1A1 P00352 1/20 0.40
GAA P10253 1/20 0.40
MCHR1 Q99705 1/20 0.40
MAPT P10636 1/20 0.40
MEN1 O00255 1/20 0.40
LMNA P02545 1/20 0.40
HTR1E P28566 1/20 0.40
HTT P42858 1/20 0.40
KMT2A Q03164 1/20 0.40
S1PR3 Q99500 1/20 0.40
CYP2D6 P10635 1/20 0.39
KCNH2 Q12809 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6042982 0.74 SLC6A2 (0.46) SLC6A3SLC6A2SLC6A4MCHR1KCNH2
SCHEMBL7110058 0.72 RAB9A (0.36) KDM4EGAAMAPTLMNA
SCHEMBL8492856 0.69 EPHX1 (0.48) ALDH1A1GAALMNAKMT2A
SCHEMBL11363300 0.68 L3MBTL1 (0.49) SLC6A3MEN1LMNAKMT2ACYP2D6
SCHEMBL6042548 0.68 SLC6A3 (0.42) SLC6A3SLC6A2SLC6A4
SCHEMBL6044044 0.68 SLC6A3 (0.42) SLC6A3SLC6A2SLC6A4
SCHEMBL6042543 0.68 SLC6A3 (0.42) SLC6A3SLC6A2SLC6A4
SCHEMBL5010541 0.67 ALDH1A1 (0.51) KDM4EALDH1A1GAAHTT
SCHEMBL6043121 0.66 CASR (0.47) ALDH1A1GAAMCHR1
SCHEMBL10120468 0.65 UGT2B7 (0.55) MEN1KMT2ACYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2002076440-A2 METHODS OF TREATING ALZHEIMER'S DISEASE WITH PIPERIDIN DERIVATES ELAN PHARMACEUTICALS, INC. (US) 2002-10-03 WO disclosed